CanID: a robust and accurate RNAseq Expression-based diagnostic classification scheme for pediatric malignancies
Authors:
- Daniel K. PutnamDPDaniel K. Putnam
- Alexander M. GoutAGAlexander M. Gout
- Delaram RahbariniaDRDelaram Rahbarinia
- Meiling JinMJMeiling Jin
- David FinkelsteinDFDavid Finkelstein
- Xiaotu MaXMXiaotu Ma
- Jinghui ZhangJZJinghui Zhang
- David A. WheelerDWDavid A. Wheeler
- Larissa V. FurtadoLFLarissa V. Furtado
- Xiang ChenXCXiang Chen
Preprint
Abstract
Cancer subtype classification is critical for precision therapy and there is a growing trend of augmenting histopathology testing procedures with omics-based machine learning classifiers. However, analytical challenges remain for pediatric cancer on the scope and precision of the current classifiers as well as the evolving subtype standardization. To address these challenges, we built Cancer Identification or CanID, a stacked ensemble machine learning classification scheme, using the transcriptomic features derived from gene-level RNA sequencing count data as the sole input. CanID was developed primarily from 3203 pediatric cancer samples of 13 solid tumor subtypes and 38 hematologic malignancy subtypes with subtype labels curated without the use of RNA-seq data. The accuracies of independent testing in three independent or external data sets for Solid Tumor and Hematologic Malignancy are 99% and 92–93%, respectively. Notably, CanID was able to classify subtypes challenging for clinical histology evaluation and was robust to both biological and technical challenges, including differences in data collection protocols, class imbalance, potential mislabeled training samples and classes unobserved in training. The high accuracy, robustness, biological interpretability of this transcriptome-based classification scheme represents a valuable approach to advance tumor diagnosis and clinically meaningful stratification of tumor types. CanID can be accessed on GitHub at https://github.com/chenlab-sj/CanID .Keywords
All Related Versions
- Published version: Genomics, Proteomics & Bioinformatics, 23 (6).
This publication has 66 references indexed in Scilit:
- Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic Leukemia in an Academic Clinical LaboratoryThe Journal of Molecular Diagnostics, 2023
- Evaluation of cell-free DNA approaches for multi-cancer early detectionCancer Cell, 2022
- A community effort to identify and correct mislabeled samples in proteogenomic studiesPatterns, 2021
- Adversarial Attacks and Defenses in Deep LearningEngineering, 2020
- Fusion status in patients with lymph node‐positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)Cancer, 2018
- Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental PathwaysCancer Cell, 2016
- Identification of sample annotation errors in gene expression datasetsArchives of Toxicology, 2015
- Core Transcriptional Regulatory Circuit Controlled by the TAL1 Complex in Human T Cell Acute Lymphoblastic LeukemiaCancer Cell, 2012
- Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic LeukemiaCancer Cell, 2011
- Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition SyndromeThe American Journal of Human Genetics, 2010